1. Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
   Hannah Onafuye et al, 2019, Beilstein J. Nanotechnol. CrossRef
2. Intact-Cell MALDI-ToF Mass Spectrometry for the Authentication of Drug-Adapted Cancer Cell Lines
   Jane F. Povey et al, 2019, Cells CrossRef
3. Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity
   Sebastian Pieper et al, 2019, Beilstein J. Nanotechnol. CrossRef
4. Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
   Martin Michaelis et al, 2020, Cancers CrossRef
5. Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells
   Mohamed Jemaà et al, 2020, IJMS CrossRef
6. Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer
   Anita Thomas et al, 2021, Cancers CrossRef
7. Cisplatin-Resistant Neuroblastoma Cells Express Enhanced Levels of Epidermal Growth Factor Receptor (EGFR) and Are Sensitive to Treatment with EGFR-Specific Toxins
   Martin Michaelis et al, 2008 CrossRef
8. p53 Determines Multidrug Sensitivity of Childhood Neuroblastoma
   Chengyuan Xue et al, 2007 CrossRef
9. Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
   Martin Michaelis et al, 2009 CrossRef
10. Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain
    K. Michaelis et al, 2006, The Journal of Pharmacology and Experimental Therapeutics CrossRef